Raised CRP levels mark metabolic and functional impairment in advanced COPD
Top Cited Papers
Open Access
- 21 October 2005
- Vol. 61 (1), 17-22
- https://doi.org/10.1136/thx.2005.041996
Abstract
Background: C-reactive protein (CRP) is often used as a clinical marker of acute systemic inflammation. Since low grade inflammation is evident in chronic diseases such as chronic obstructive pulmonary disease (COPD), new methods have been developed to enhance the sensitivity of CRP assays in the lower range. A study was undertaken to investigate the discriminative value of high sensitivity CRP in COPD with respect to markers of local and systemic impairment, disability, and handicap. Methods: Plasma CRP levels, interleukin 6 (IL-6) levels, body composition, resting energy expenditure (REE), exercise capacity, health status, and lung function were determined in 102 patients with clinically stable COPD (GOLD stage II–IV). The cut off point for normal versus raised CRP levels was 4.21 mg/l. Results: CRP levels were raised in 48 of 102 patients. In these patients, IL-6 (p1 (p = 0.031) and reversibility (p = 0.001). Regression analysis also showed that, when adjusted for FEV1, age and sex, CRP was a significant predictor for body mass index (p = 0.044) and fat mass index (p = 0.016). Conclusions: High sensitivity CRP is a marker for impaired energy metabolism, functional capacity, and distress due to respiratory symptoms in COPD.Keywords
This publication has 40 references indexed in Scilit:
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax, 2004
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?Proceedings Of The Nutrition Society, 2004
- What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysisEuropean Respiratory Journal, 2003
- Bedside methodsversusdual energy X‐ray absorptiometry for body composition measurement in COPDEuropean Respiratory Journal, 2002
- Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen contentThe FASEB Journal, 2001
- Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbationsThorax, 2001
- C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in menPublished by Oxford University Press (OUP) ,2000
- Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPDThorax, 2000
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999